第一作者机构:[1]Fu Dan Univ, Shanghai Dao Pei Hosp, BMT Ctr, Shanghai, Peoples R China[2]Amer Yuva Biomed, Beijing, Peoples R China
推荐引用方式(GB/T 7714):
Dong Lujia,Chang Lung-Ji,Gao Zhiyong,et al.Chimeric Antigen Receptor 4SCAR19-Modified T Cells in Acute Lymphoid Leukemia: a Phase II Multi-Center Clinical Trial in China[J].BLOOD.2015,126(23):
APA:
Dong, Lujia,Chang, Lung-Ji,Gao, Zhiyong,Lu, Dao-Pei,Zhang, Jian-Ping...&Lai, Xun.(2015).Chimeric Antigen Receptor 4SCAR19-Modified T Cells in Acute Lymphoid Leukemia: a Phase II Multi-Center Clinical Trial in China.BLOOD,126,(23)
MLA:
Dong, Lujia,et al."Chimeric Antigen Receptor 4SCAR19-Modified T Cells in Acute Lymphoid Leukemia: a Phase II Multi-Center Clinical Trial in China".BLOOD 126..23(2015)